Fitbit has completed clinical trials of its own ECG feature and is looking to get FDA approval – as it launches a large scale study into Afib and irregular heart rate detection. The mass Fitbit Heart ...

NEW YORK--(BUSINESS WIRE)--AccurKardia, an innovator in ECG-based diagnostics technology, has announced the initiation of a multicenter clinical pilot of AK+ Guard TM, an FDA Breakthrough Device ...

HeartBeam’s synthesised 12-lead electrocardiogram (ECG) has met the clinical endpoints in the VALID-ECG pivotal study, assessing non-life-threatening arrhythmias. In the study, the mean difference in ...

The electrocardiogram built into recent Apple Watch models isn’t likely to give wearers false notifications that they have atrial fibrillation, a potentially dangerous heart condition. A clean bill of ...

Please provide your email address to receive an email when new articles are posted on . Abnormal ECG findings were rare in elite female basketball players. These data may serve as a reference for ...

A study observed how well researchers could interpret ECG data from various wearables, and Apple Watch came out as the most favorable but is no better at detecting atrial fibrillation than others.

(RTTNews) - HeartBeam, Inc., (BEAT), a medical technology company, Tuesday said its synthesized 12-lead electrocardiogram (ECG) met the clinical endpoints in the VALID-ECG pivotal study. The study ...

A study published in Nature Medicine reports the ability of a smartwatch ECG to accurately detect heart failure in nonclinical environments. Researchers at Mayo Clinic applied artificial intelligence ...